Bruker Corp (BRKR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

40 MANNING RD BILLERICA, MA 01821

Designs, manufactures, services and markets proprietary life science systems based on mass spectrometry core technology platforms and X-ray technology. The company also sells a broad range of field analytical systems for nuclear, biological and chemical detection.

Data as of 2020-07-04
Market Cap6.401 Billion Shares Outstanding154.23 Million Avg 30-day Volume635.877 Thousand
P/E Ratio36.7 Dividend Yield0.386 EPS1.13
Price/Sales4.143 Price cash flow ratio27.6 Price free cash flow ratio71.1
Book Value5.94 Price to Tangible Book15.83 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.400964
BETA1.37499 52-week High/Low54.49 / 30.78 Stddev0.09247
View SEC Filings from BRKR instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 238 63 (4.13%)
Aggregate 13F shares on 03/31/2020: 107.825 Million 50.316 Million
Aggregate 13F shares on 12/31/2019: 107.001 Million 45.879 Million
Percent change: 0.77% 9.67%
Funds creating new positions: 31 7
Funds Adding to an existing position: 70 20
Funds closing out their position: 63 25
Funds reducing their position: 100 33
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 
Bruker Corp Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding BRKR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BRKR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2.5 Thousand total shares from 1 transactions

Open Market Sells (S)

32.8 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

30 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROSENTHAL BOB EXECUTIVE CHAIRMAN

  • Officer
  • Director
 37,710 2020-06-30 1

FRIEND CYNTHIA M

  • Director
 11,857 2020-06-22 3

KNELL MICHAEL GUNNAR CSVP&CHIEF ACCOUNTING OFFICER

  • Officer
 2,414 2020-05-29 0

LAUKIEN FRANK H CEO, PRESIDENT

  • Officer
  • Director
  • 10% Owner
 40,077,130 2020-05-11 5

MARTIN GILLES GERARD JEAN

  • Director
 14,657 2020-05-11 2

PACKER RICHARD A

  • Director
 2,713 2020-05-05 2

WAGNER CHARLES F JR EVP AND CFO

  • Officer
 16,727 2020-04-30 0

PERKINS ADELENE Q CHIEF EXECUTIVE OFFICER

  • Officer
 809,637 2020-01-10 1

LINTON WILLIAM A

  • Director
 79,407 2020-01-06 2

KASTNER MARC A

  • Director
 10,080 2020-01-06 2

REQUARDT HERMANN FRITZ

  • Director
 14,657 2020-01-06 1

ORNELL JOHN A

  • Director
 14,657 2020-01-06 1

MUNCH MARK EXEC VP&PRES BRUKER NANO INC.

  • Officer
 78,713 2019-10-04 5

PRAUSE BURKHARD PRES. & CEO, BRUKER EST

  • Officer
 49,782 2019-09-05 3

SREGA JUERGEN GROUP PRESIDENT BRUKER CALID

  • Officer
 109,529 2019-08-08 1

HERMAN GERALD N VICE PRESIDENT, CFO

  • Officer
 27,263 2019-08-08 1

BUSSE FALKO PRESIDENT, BIOSPIN GROUP

  • Officer
 15,181 2019-08-08 1

MATTACCHIONE ANTHONY L SENIOR VICE PRESIDENT & CFO

  • Officer
 33,671 2018-02-20 0

LAUKIEN JOERG C

  • Director
 15,215,769 2018-01-05 0

KNISS RICHARD

  • Director
 44,227 2018-01-05 0

VAN INGEN CHRIS

  • Director
 4,577 2017-06-14 0

LENGGENHAGER RENE PRESIDENT, BIOSPIN GROUP

  • Officer
 11,037 2017-02-24 0

FESIK STEPHEN W.

  • Director
 4,577 2017-01-05 0

EMMERICH WOLF-DIETER

  • Director
 0 2016-05-09 0

FURLONG BRENDA J

  • Director
 1,000 2016-05-09 0

BACHMANN THOMAS WERNER PRESIDENT BRUKER BIOSPIN GROUP

  • Officer
 27,700 2014-08-08 0

WANGLER BERNHARD

  • Director
 0 2014-01-06 0

MAAS WERNER PRESIDENT, BRUKER BIOSPIN CORP

  • Officer
 0 2013-08-30 0

GEWIESE BERND PRESIDENT, BRUKER BIOSPIN CORP

  • Officer
 0 2013-08-30 0

WESTERMANN STEPHAN EVP-OEP&L

  • Officer
 0 2012-03-07 0

KELLER TONY WERNER

  • Director
 0 2012-01-05 0

MONAHAN BRIAN P VP - STRATEGIC PLANNING

  • Officer
 0 2011-09-09 0

KNIGHT WILLIAM J COO/INTERIM CFO

  • Officer
 0 2011-09-09 0

LAUKIEN DIRK D

  • Director
  • 10% Owner
 15,862,972 2011-03-14 0

STEIN RICHARD M SECRETARY

  • Officer
  • Director
 3,349 2010-11-19 0

DSILVA COLLIN J

  • Director
 7,000 2010-01-12 0

LAUKIEN ISOLDE

  • 10% Owner
 No longer subject to file 2009-09-22 0

LAUKIEN MARC M

  • 10% Owner
 No longer subject to file 2009-05-07 0

DROSS DANIEL

  • Director
 0 2008-01-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FRIEND CYNTHIA M - Director

2020-06-22 S 1,800 $40.57 d 11,857 11,857.00 direct

FRIEND CYNTHIA M - Director

2020-05-11 S 1,000 $39.06 d 13,657 13,657.00 direct

LAUKIEN FRANK H - Director - Officer - > 10% Owner CEO, PRESIDENT

2020-05-11 P 2,500 $39.11 a 38,068,625 40,077,130.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 M 10,000 d 0 14,657.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 M 10,000 $19.12 a 34,657 14,657.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 M 10,000 d 0 14,657.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 S 30,000 $38.83 a 14,657 14,657.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 M 10,000 $21.74 a 24,657 14,657.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 M 10,000 d 0 14,657.00 direct

MARTIN GILLES GERARD JEAN - Director

2020-05-11 M 10,000 $24.00 a 44,657 14,657.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments